From 9 Nov the government will limit distributor and hospital mark‑ups on 137 cancer medicines to 30% of the maximum retail price, a move the health ministry says could save patients billions.
The Union government's move to cap cancer medicine trade margins at 30% will save patients ₹2,500 crore annually, but judges want to know if other treatments can follow.
The state's controversial food and drug regulator has shut down a major pharmaceutical warehouse and is now taking on the fast-growing dietary supplement market.
